Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced the appointment of Federico A. Monzon, M.D. FCAP, to the newly created role of Chief Medical Officer.  The Company also announced the appointment of Greg Schafer to Executive Director of Managed Care.

Read More